Table 2.
Qualitative description of metabolic syndrome subcomponents prevalence within included studies
| Author and publication year | Metabolic syndrome subcomponent | ||
|---|---|---|---|
| HIV+ | HIV− | ||
| 1 | Amusa et al., 2016 [33] | Hypertension, diabetes, visceral obesity | Hypertension, diabetes, visceral obesity |
| 2 | Ayodele et al., 2012 [32] | Hypertension, diabetes, visceral obesity, high triglyceride, low HDL cholesterol | – |
| 3 | Berhane et al., 2012 [34] | Hypertension, diabetes, visceral obesity, high triglyceride | – |
| 4 | Tesfaye et al., 2014 [42] | Hypertension, diabetes, high triglyceride, low HDL cholesterol | – |
| 5 | Sobieszczyk et al., 2016 [29] | Diabetes, visceral obesity, high triglyceride, low HDL cholesterol | – |
| 6 | Obirikorang et al., 2016 [41] | – | – |
| 7 | Ngatchou et al., 2013 [40] | Diabetes | Diabetes |
| 8 | Fourie et al., 2010 [35] | Hypertension, diabetes, visceral obesity, high triglyceride, low HDL cholesterol | Hypertension, diabetes, visceral obesity, high triglyceride, low HDL cholesterol |
| 9 | Muhammad et al., 2013 [45] | Hypertension, diabetes, low HDL cholesterol | – |
| 10 | Mbunkah et al., 2014 [38] | Hypertension | – |
| 11 | Guehi et al., 2016 [30] | Hypertension, diabetes, visceral obesity, high triglyceride | – |
| 12 | Mashinya et al., 2015 [37] | Hypertension, diabetes, high triglyceride, low HDL cholesterol | – |
| 13 | Guira et al., 2016 [31] | Hypertension, diabetes, high triglyceride, low HDL cholesterol | – |
| 14 | Hirigo et al., 2016 [36] | Hypertension, diabetes | – |
| 15 | Zannou et al., 2009 [28] | Hypertension, diabetes, visceral obesity, high triglyceride | – |
| 16 | Muyanja et al., 2016 [39] | Hypertension, high triglyceride, low HDL cholesterol | – |
| 17 | Adébayo et al., 2015 [44] | Hypertension, diabetes, high triglyceride | Hypertension, diabetes, visceral obesity |
| 18 | Sawadogo et al., 2005 [43] | Diabetes | – |